
    
        <!DOCTYPE html>
        <html lang="hu-HU" data-website-id="1" data-oe-company-name="HBS Medical">
            
<!-- Mirrored from hbs.hu/slides/slide/hyaluronic-acid-an-effective-alternative-treatment-of-interstitial-cystitis-recurrent-urinary-tract-infections-and-hemorrhagic-cystitis-50 by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 31 May 2021 16:22:22 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
                <meta charset="utf-8"/>
                <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
                <meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no"/>

                <title>Hyaluronic Acid- An Effective Alternative Treatment of Interstitial Cystitis, Recurrent Urinary Tract Infections, and Hemorrhagic Cystitis | HBS</title>
                <link type="image/x-icon" rel="shortcut icon" href="../../web/image/website/1/favicon/index.html"/>

                <script type="text/javascript">
                    var odoo = {
                        csrf_token: "f2e9a41588799d043a772b21ddc3189150ea199fo",
                    };
                </script>

                
            <meta name="generator" content="Odoo"/>

            
            
            
            
            
            
                
                
                
                    
                        <meta property="og:type" content="website"/>
                    
                        <meta property="og:title" content="Hyaluronic Acid- An Effective Alternative Treatment of Interstitial Cystitis, Recurrent Urinary Tract Infections, and Hemorrhagic Cystitis"/>
                    
                        <meta property="og:site_name" content="HBS Medical"/>
                    
                        <meta property="og:url" content="https://hbs.hu/slides/slide/hyaluronic-acid-an-effective-alternative-treatment-of-interstitial-cystitis-recurrent-urinary-tract-infections-and-hemorrhagic-cystitis-50"/>
                    
                        <meta property="og:image" content="https://hbs.hu/web/image/slide.slide/50/image_thumb"/>
                    
                        <meta property="og:description"/>
                    
                
                
                
                    
                        <meta name="twitter:card" content="summary_large_image"/>
                    
                        <meta name="twitter:title" content="Hyaluronic Acid- An Effective Alternative Treatment of Interstitial Cystitis, Recurrent Urinary Tract Infections, and Hemorrhagic Cystitis"/>
                    
                        <meta name="twitter:image" content="https://hbs.hu/web/image/slide.slide/50/image_thumb"/>
                    
                        <meta name="twitter:description"/>
                    
                
            

            
            
                
                    <link rel="alternate" hreflang="hu" href="hyaluronic-acid-an-effective-alternative-treatment-of-interstitial-cystitis-recurrent-urinary-tract-infections-and-hemorrhagic-cystitis-50.html"/>
                
            

            <script type="text/javascript">
                odoo.session_info = {
                    is_admin: false,
                    is_system: false,
                    is_frontend: true,
                    translationURL: '/website/translations',
                    is_website_user: true,
                    user_id: 4
                };
                
            </script>

            <link type="text/css" rel="stylesheet" href="../../web/content/521-3ab7b2c/1/web.assets_common.0.css"/>
            <link type="text/css" rel="stylesheet" href="../../web/content/599-e81acc7/1/web.assets_frontend.0.css"/>
            <link type="text/css" rel="stylesheet" href="../../web/content/600-e81acc7/1/web.assets_frontend.1.css"/>
            
            
            

            <script type="text/javascript" src="../../web/content/524-3ab7b2c/1/web.assets_common.js"></script>
            <script type="text/javascript" src="../../web/content/603-e81acc7/1/web.assets_frontend.js"></script>
            
            
            
        
            </head>
            <body>
                
            
        
            
        
        
            
                
                    
                
                
            
        
        
    
    

            
            
        
    
            
          
        <link rel="stylesheet" type="text/css" href="../../sh_cookie_notice/static/src/css/cookieconsent.min.css"/>
        <script type="text/javascript" src="../../sh_cookie_notice/static/src/js/cookieconsent.min.js"></script>
        

	
	<script type="text/javascript"> 

	 window.addEventListener("load", function(){
 
	var sh_msg = String("Az HBS weboldala sütiket használ a weboldal működtetése, használatának megkönnyítése, a weboldalon végzett tevékenység nyomon követése és releváns ajánlatok megjelenítése érdekében.");
	var sh_esc_msg = encodeURIComponent(sh_msg);
	sh_esc_msg = decodeURIComponent(sh_esc_msg); 
	
  	window.cookieconsent.initialise({
	  "palette": {
	    "popup": {
	      "background": "#000" 
	    },
	    "button": {
	      "background": "#f1d600"
	    }
	  },
	  
	  	  "position": "top",
	  
	
	  
	  "content": {
	    "message": sh_esc_msg,
	    "dismiss": "Elfogadom",
	    "allow": "allow",
	    "link": "Adatvédelmi tájékoztató",
	    "href": "/adatkezelesi-tajekoztato"
	  }
	})});
    </script>
 
   
    <div id="wrapwrap" class="   ">
                <header class=" o_affix_enabled">
                    <nav class="navbar navbar-expand-md navbar-light bg-light">
                        <div class="container">
                            <a href="../../index.html" class="navbar-brand logo">
            <span role="img" aria-label="Logo of HBS Medical" title="HBS Medical"><img src="../../web/image/res.company/1/logo66cf.png?unique=866a03a" class="img img-fluid"/></span>
        </a>
    <button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#top_menu_collapse">
                                <span class="navbar-toggler-icon"></span>
                            </button>
                            <div class="collapse navbar-collapse" id="top_menu_collapse">
                                <ul class="nav navbar-nav ml-auto text-right o_menu_loading" id="top_menu">
                                    
        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../index.html" class="nav-link ">
            <span>HBS Medical</span>
        </a>
    </li>
    

        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../../covid-19.hbs.hu/index.html" class="nav-link " target="_blank">
            <span>COVID-19</span>
        </a>
    </li>
    

        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../blog/hirek-esemenyek-1.html" class="nav-link ">
            <span>Hírek</span>
        </a>
    </li>
    

        
            
    
    <li class="nav-item">
        <a role="menuitem" href="../../aboutus.html" class="nav-link ">
            <span>Kapcsolat</span>
        </a>
    </li>
    

        
    
                                    
                                </ul>
                            </div>
                        </div>
                    </nav>
                </header>
                <main>
                    
        
        <div class="container mt16">
            <div class="row">
                <div class="col-xl-8 col-lg-8 col-md-12 col-12">
                    

                    <div>
                            
                        <div class="embed-responsive embed-responsive-4by3 embed-responsive-item mb8">
                            <iframe src="../embed/502679.html?page=1" class="o_wslides_iframe_viewer" allowFullScreen="true" height="315" width="420" frameborder="0"></iframe>
                        </div>
                        
                        <div class="row">
                            <h4 class="col-lg-6">Hyaluronic Acid- An Effective Alternative Treatment of Interstitial Cystitis, Recurrent Urinary Tract Infections, and Hemorrhagic Cystitis</h4>
                            <div class="col-lg-6">
                                <div clas="row">
                                    
                                </div>
                            </div>
                        </div>
                        <div class="row">
                            <div class="col-md-8 col-12">
                                <div class="float-left">
                                    <a href="../nyilvanos-anyagok-1.html" title="Channel Nyilvános anyagok" aria-label="Channel Nyilvános anyagok">
                                        <i class="fa fa-circle-o fa-5x" style="color: #875A7B;font-weight: bold;"></i>
                                    </a>
                                </div>
                                <div style="margin-left: 80px">
                                    <p>
                                        <a href="../nyilvanos-anyagok-1.html">Nyilvános anyagok</a>
                                        
                                            <span> / </span>
                                            <a href="../nyilvanos-anyagok-1/category/szakirodalmi-cikkek-3.html">Szakirodalmi cikkek</a>
                                        
                                    </p>
                                    <div>
                                        
        <div class="input-group js_follow" data-id="1" data-object="slide.channel" data-follow="off">
            <input type="email" name="email" class="js_follow_email form-control" placeholder="emailje..."/>
            <div class="input-group-append">
                <button href="#" class="btn btn-secondary js_unfollow_btn">Leiratkozás</button>
                <button href="#" class="btn btn-primary js_follow_btn">Feliratkozás</button>
            </div>
        </div>
    
                                    </div>
                                </div>
                            </div>
                            <div class="col-md-4 d-none d-md-block">
                                <div class="text-right">
                                    <b class="h3 text-muted">1249</b> <span class="text-muted small">views</span>
                                </div>
                                
                                <div class="progress mb0" style="height: 2px;">
                                    <div class="progress-bar" role="progressbar" aria-valuenow="0" aria-valuemin="0" aria-valuemax="100" style="width: 0%;">
                                        <span class="sr-only">0 Likes</span>
                                    </div>
                                </div>
                                <div class="text-muted mt4">
                                    <div class="float-right mb16 text-right">
                                        <span class="oe_slide_js_like" data-href="/slides/slide/like" tabindex="0" data-toggle="popover" data-user-id="4" data-public-user="True" data-slide-id="50">
                                            <i class="fa fa-thumbs-up fa-1x" role="img" aria-label="Likes" title="Likes"></i>
                                            0
                                        </span>
                                        <span class="oe_slide_js_unlike" data-href="/slides/slide/dislike" tabindex="0" data-toggle="popover" data-user-id="4" data-public-user="True" data-slide-id="50">
                                            <i class="fa fa-thumbs-down fa-1x" role="img" aria-label="Dislikes" title="Dislikes"></i>
                                            0
                                        </span>
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="mt8 mb32">
                            <ul class="nav nav-tabs" role="tablist">
                                <li class="nav-item">
                                    <a href="#about" aria-controls="about" role="tab" data-toggle="tab" class="nav-link active">
                                        <i class="fa fa-home"></i> About
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#share" aria-controls="share" class="nav-link" role="tab" data-toggle="tab">
                                        <i class="fa fa-share-alt"></i> Share
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#discuss" aria-controls="discuss" role="tab" data-toggle="tab" class="nav-link">
                                        <i class="fa fa-comments-o"></i> Comments
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#transcript" aria-controls="transcript" class="nav-link" role="tab" data-toggle="tab">
                                        <i class="fa fa-align-justify"></i> Transcript
                                    </a>
                                </li>
                                <li class="nav-item">
                                    <a href="#statistic" aria-controls="statistic" class="nav-link" role="tab" data-toggle="tab">
                                        <i class="fa fa-bar-chart"></i> Statistics
                                    </a>
                                </li>
                            </ul>
                            <div class="tab-content" style="padding: 20px 5px 5px 5px; word-wrap: break-word;">
                                <div role="tabpanel" id="about" class="tab-pane fade active in">
                                    
                                </div>
                                <div role="tabpanel" class="tab-pane fade" id="share">
                                    
    <h4 class="mt0">Share on Social Networks</h4>
    
    <div>
        <a class="o_slides_social_share" social-key="facebook" aria-label="Share on Facebook" title="Share on Facebook" href="https://www.facebook.com/sharer/sharer.php?u=https://hbs.hu/r/y21"><i class="fa fa-facebook-square fa-2x"></i></a>
        <a class="o_slides_social_share" social-key="twitter" aria-label="Share on Twitter" title="Share on Twitter" href="https://twitter.com/intent/tweet?text=Hyaluronic%20Acid-%20An%20Effective%20Alternative%20Treatment%20of%20Interstitial%20Cystitis,%20Recurrent%20Urinary%20Tract%20Infections,%20and%20Hemorrhagic%20Cystitis&amp;url=https://hbs.hu/r/y21"><i class="fa fa-twitter fa-2x"></i></a>
        <a social-key="linkedin" class="o_slides_social_share" aria-label="Share on LinkedIn" title="Share on LinkedIn" href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://hbs.hu/r/y21&amp;title=Hyaluronic%20Acid-%20An%20Effective%20Alternative%20Treatment%20of%20Interstitial%20Cystitis,%20Recurrent%20Urinary%20Tract%20Infections,%20and%20Hemorrhagic%20Cystitis&amp;"><i class="fa fa-linkedin fa-2x"></i></a>
        <a class="o_slides_social_share" social-key="gplus" aria-label="Share on Google Plus" title="Share on Google Plus" href="https://plus.google.com/share?url=https://hbs.hu/r/y21"><i class="fa fa-google-plus-square fa-2x"></i></a>
    </div>

    <h4 class="mt-3">Share Link</h4>
    <input type="text" class="form-control" readonly="readonly" onClick="this.select();" value="hyaluronic-acid-an-effective-alternative-treatment-of-interstitial-cystitis-recurrent-urinary-tract-infections-and-hemorrhagic-cystitis-50.html"/>
    <span class="form-text">Use permanent link to share in social media</span>

                                    
    <h4 class="mt-3">Share with a friend</h4>
    
    
        <p>Please <a href="../../web/login.html?redirect=https://hbs.hu/slides/slide/hyaluronic-acid-an-effective-alternative-treatment-of-interstitial-cystitis-recurrent-urinary-tract-infections-and-hemorrhagic-cystitis-50"> login </a> to send this document by email!</p>
    

                                    
                                        
    <div class="oe_slide_js_embed_code_widget">
        <h4 class="mt0">Embed in your website</h4>
        <div class="form-group">
            <textarea class="form-control slide_embed_code" readonly="readonly" onClick="this.select();">&lt;iframe src=&quot;https://hbs.hu/slides/embed/50?page=1&quot; class=&quot;o_wslides_iframe_viewer&quot; allowFullScreen=&quot;true&quot; height=&quot;315&quot; width=&quot;420&quot; frameborder=&quot;0&quot;&gt;&lt;/iframe&gt;</textarea>
        </div>
        <div class="form-group">
            <div class="form-text col-xl-3 col-lg-3 col-md-6 col-6">Select page to start with</div>
            <div class="input-group col-xl-3 col-lg-3 col-md-6 col-6">
                <input type="number" value="1" class="form-control"/>
            </div>
        </div>
    </div>

                                    
                                </div>
                                
                                <div role="tabpanel" id="discuss" class="tab-pane fade">
                                    
        <div id="discussion" class="d-print-none o_portal_chatter o_not_editable p-0" data-res_model="slide.slide" data-res_id="50" data-pager_step="10" data-allow_composer="1">
        </div>
    
                                </div>
                                <div role="tabpanel" class="tab-pane fade oe_slides_transcript" id="transcript">
                                    
                                        
                                            <p>4. Constantinides et al [12] 2004       40                                                   Mean: 35 (range: 18–45) Recurrent UTIs                          4 weekly doses plus 4 monthly doses 40/40: recurrence free during 5 mo                            12.4 mo 28/40 (70%): recurrence free during follow-up Median time of recurrence 498 d (compared with 96 d before treatment) Excellent tolerability 9/40 mild bladder irritation 40/40 compliance Leppilahti et al [38] 2002       11                                                   Mean: 64.5 (range: 51–76) Interstitial cystitis                     4 weekly doses                     8/11 responders                                                             1 yr 3/8 long-term responders 5/8 short-term responders Responders: 75% decrease in pain Long-term responders: 40% decrease in frequency Short-term responders: 26% % decrease in frequency Nordling et al [26] 2001       20                                                                                  Interstitial cystitis                     4 weekly doses plus monthly doses for 2 mo 1/20 withdrawn due to cystectomy                            3 yr 7/19 responders 6/19 nonresponders 4/19 recovered during treatment 2/19 stopped before follow-up Morales et al [3] 1997       25                                                                                  Interstitial cystitis                     4 weekly doses plus monthly doses for 1 yr responders 16% complete response by week 4                             6 mo 25% complete response by week 24 56% response (complete or partial) for week 4 71% response (complete or partial) by week 12 71% response (complete or partial) till week 20 Decrease beyond rate 24 weeks No significant toxicity 1/25 withdrew because of exacerbation of bladder irritability Porru et al [39] * 1997       10                                                                                  Interstitial cystitis                     6 weekly doses plus monthly doses 30% response in 6 weeks                                              6 mo 30% response in 24 weeks No significant local or general side effects Well tolerated HSCT = hematopoietic stem cell transplant; C max = maximum plasma concentration; PST = potassium sensitivity test; UK = United Kingdom; UTI = urinary tract infection. * These three studies were randomised controlled trials. The studies by Gupta et al and Porru et al were double-blinded, placebo-controlled trials. Po rru et al did not report the method used for double-blinding, while Gupta et al reported that the pharmacy supplied the medications in bottles labeled A and B to ensure double-blinding. european urology 51 (2007) 1534–1541 1537 </p>
                                        
                                            <p>8. documented. We await, with interest, publication of well-conducted,   randomized,   placebo-controlled trials evaluating the use of intravesical hyaluronic acid for any urologic syndrome. References [1]  Iavazzo C, Athanasiou  S, Pitsouni E, Falagas ME. Hya- luronic acid: an effective alternative treatment of inter- stitial  cystitis,  recurrent  urinary  tract  infections,  and hemorrhagic cystitis? Eur Urol 2007;51:1534–41. [2]  Gupta SK, Pidcock L, Parr NJ. The potassium sensitivity test:  a  predictor  of  treatment  response  in  interstitial cystitis. BJU Int 2005;96:1063–6. [3]  Porra D, Tinelli C, Gerardini M, et al. Results of treatment of  refractory interstitial cystitis  with  intravesical  hya- luronic acid. Urol Int 1997;59:26–9. DOI: 10.1016/j.eururo.2007.03.021 DOI of original article: 10.1016/j.eururo.2007.03.020 european urology 51 (2007) 1534–1541 1541 </p>
                                        
                                            <p>7. [22]  Gupta SK, Pidcock L, Parr NJ. The potassium sensitivity test:  a  predictor  of  treatment  response  in  interstitial cystitis. BJU Int 2005;96:1063–6. [23]  Parsons CL, Stein PC, Bidair M, et al. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radia- tion cystitis. Neurourol Urodyn 1994;13:515–20. [24]  Moldwin RM, Sant GR. Interstitial cystitis: a pathophysiol- ogy and treatment update. Clin Obstet Gynecol 2002;45: 259–72. [25]  Morales A, Emerson L, Nickel JC. Treatment of refractory interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 1996;7:215–20. [26]  Nordling  J,  Jorgensen  S,  Kallestrup  E.  Cystistat  for  the treatment of interstitial cystitis: a 3-year follow-up study. Urology 2001;57(6 suppl 1):123. [27]  Lokeshwar  VB,  Selzer  MG,  Unwala  DJ,  et  al.  Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity. J Urol 2006;176:1001–7. [28]  Ruggieri MR, Chelsky MJ, Rosen SI, et al. Current findings and future research avenues in the study of interstitial cystitis. Urol Clin North Am 1994;21:163–76. [29]  Parsons  C.  Current  strategies  for  managing  interstitial cystitis. Expert Opin Pharmacother 2004;5:287–93. [30]  Parsons  CL,  Housley T,  Schmidt JD,  et  al. Treatment  of interstitial  cystitis  with  intravesical  heparin.  Br  J  Urol 1994;73:504–7. [31]  Parsons CL. Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysul- fate. J Urol 1982;127:167–9. [32]  Toft BR, Nordling J. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review. Curr Opin Urol 2006;16:268–72. [33]  Falagas   ME,   Gorbach   SL.   Urinary   tract   infections: practice   guidelines.   Infect   Dis   Clin   Practice   1995;4: 241–57. [34]  Sobota AE. Inhibition of bacterial adherence by cranberry juice;  potential  use  for  the  treatment  of  urinary  tract infections. J Urol 1984;131:1013–6. [35]  Falagas ME, Betsi GI, Tokas T, et al. Probiotics for preven- tion  of  recurrent  urinary  tract  infections  in  women:  a review of the evidence from microbiological and clinical studies. Drugs 2006;66:1253–61. [36]  Riedl CR, Daha LK, Pfluger H, et al. Intravesical hyaluronic acid  for   the  treatment  of   interstitial   cystitis.  J  Urol 2003;169(Suppl A):265. [37]  Gupta SK. Re: Daha LK, Riedl CR, Lazar D, Hohlbrugger G, Pflu  ̈ ger H. Do cystometric findings predict the results of intravesical  hyaluronic  acid  in  women  with  interstitial cystitis? Eur Urol 2005;47:393–7. Eur Urol 2005;48:534. [38]  Leppilahti M, Hellstrom P, Tammela TL. Effect of diag- nostic hydrodistension and four intravesical hyaluronic acid   instillations   on   bladder   ICAM-1   intensity   and association  of  ICAM-1  intensity  with  clinical  response in  patients  with  interstitial  cystitis.  Urology  2002;60: 46–51. [39]  Porru D, Tinelli C, Gerardini M, et al. Results of treatment of refractory interstitial cystitis with intravesical hyaluro- nic acid. Urol Int 1997;59:26–9. Editorial Comment on: Hyaluronic Acid: An Effective Alternative Treatment of Interstitial Cystitis, Recurrent Urinary Tract Infections, and Hemorrhagic Cystitis? Lindsay E. Nicolle Departments of Internal Medicine and Medical Microbiology, University of Manitoba, Winnipeg, MB R3A 1R9, Canada <a href="../../cdn-cgi/l/email-protection.html" class="__cf_email__" data-cfemail="d9b5b7b0bab6b5b5bc99b1aabaf7b4bbf7bab8">[email&#160;protected]</a> In   this   issue,   Iavazzo   et   al   review   studies evaluating  the  use  of  intravesical  instillation  of hyaluronic acid, a glucosaminoglycan replacement therapy,  for  management  of  interstitial  cystitis, recurrent  urinary  tract  infection,  or  hemorrhagic cystitis [1] . The hyaluronic acid solution is instilled directly into the bladder, and repeated instillations are  necessary.  An  effective  treatment  for  any  of these  clinical  entities  could  be  enthusiastically embraced. However, these syndromes are charac- terized by remission and relapse and the short-term course for any given patient cannot be predicted. Unfortunately,  as  the  review  concludes,  avail- able studies are limited in number and quality. The authors identified only nine studies: one involving 40 patients with urinary infection, one examining 5  patients  with  hemorrhagic  cystitis,  and  seven studies on interstitial cystitis. They identify flaws, including statistical methodology and reporting of adverse effects. Only three studies were random- ized   trials,   one   of   which   used   two   different regimens of hyaluronic acid. Although the authors suggest  two  studies  were  double-blind  and  pla- cebo-controlled, both of these, on inspection, are uncontrolled ‘‘before and after’’ studies [2,3] . Thus, the knowledge base is insufficient to support any conclusion   about   the   role   of   hyaluronic   acid bladder instillations. Placebo-controlled trials are essential to assess the  efficacy  of  any  therapy  for  chronic  diseases without an accepted optimal treatment and with an unpredictable clinical course. For interstitial cystitis and recurrent urinary tract infection, prospective, randomized, placebo-controlled trials of potential therapies  have  repeatedly  been  published;  such studies  are  certainly  feasible.  It  is  unfortunate that   any   potentially   effective   therapy   has   not been  evaluated  in  appropriate  clinical  trials  and unfair  to  promote  interventions  to  patients  who suffer from distressing illnesses before efficacy is european urology 51 (2007) 1534–1541 1540 </p>
                                        
                                            <p>3. Table 1 – The role of intravesical use of hyaluronic acid in cystitis Author                Year                     No. of patients Age (yr)              Treatment of                           Treatment scheme Results                                       Follow-up Miodosky et al [2] 2006       7                                                                                    Hemorrhagic cystitis after HSCT 4 weekly doses plus monthly doses 5/7 complete response at a median of 12 d (range: 7–23) 1/7 partial response 1/7 no response (death from septic shock) No local or systemic side effects Daha et al [19] * 2005       48                                                   Mean: 54 (range: 22–82) Interstitial cystitis (but a bladder capacity of &gt; 350 cc on a 0.9% NaCl cystometry was accepted) 10 weekly doses                   41/48 improvement                                                       6 mo (3–16 mo) 32/48 patients with aC max of &lt; 350 cc (group 1) 27/32 (84%) in group 1 16/48 patients with aC max of &gt; 350 cc (group 2) 14/16 (87%) in group 2 Gupta et al [22] * 2005       38                                                                                  Interstitial cystitis                     6 weekly doses and choice of continuing monthly in responders 20/36 improvement (55%) after 6 doses (74% of PST-positive patients and 23% of PST-negative patients) 3 patients referred pain 3 patients developed UTI Current cost: UK 120 pounds, excluding nursing and day-surgical unit costs Inconvenience of weekly visits Loss of working time and earnings Kallestrup et al [20] 2005       20                                                   34–80                     Interstitial cystitis                     4 weekly doses plus 2 monthly doses plus choice of continuing monthly in responders 40% decrease in nocturia                                             3 yr 30% decrease in pain Decrease in analgesic use 13/20 responders (65%) 6/20 lack of response 1/20 withdrawn due to cystectomy Well tolerated by all patients 5/20 bacterial cystitis due to repeated catheterisation No correlation between efficacy and time of retained solution in the bladder After 3 yr: 4/13 complete responders, 7/13 partial responders 2/13 other diseases during follow-up european urology 51 (2007) 1534–1541 1536 </p>
                                        
                                            <p>6. potassium chloride test, and pre- and protreatment analyses  were  done.  While  this  methodology  has several advantages, we should emphasize that this new therapeutic modality was not compared with other   commonly   used   therapeutic   options   in patients  with  the  examined  diseases.  In  addition, the statistical significance and the cut-off of signifi- cance  were  reported  in  only  six  of  the  reviewed articles, the number of dropouts from the study and the  reason  that  led  participants  to  dropout  were reported in three articles, and specific information regarding adverse events of intravesical treatment with hyaluronic acid in were reported in six articles. Finally,  it  should  be  emphasized  that  intravesical hyaluronic acid is not an approved treatment for the examined  indications  in  the  United  States  and United Kingdom at the time of writing of this article (November 2006). 11.    Conclusions There  is  a  scarcity  of  data  regarding  the  mode  of action of hyaluronic acid as well as its effectiveness for the examined diseases in this article. The limited available  evidence  from  the  reviewed  studies  sug- gests  that  hyaluronic  acid  may  be  considered  for further  studies,  including  randomized  controlled trials  with  adequate  power.  These  clinical  trials should be disease-specific, blinded, and controlled, and  include   a   sufficient  number  of  patients   to answer the important relevant study questions. Until such   studies   are   available,   the   effectiveness   of intravesical   instillation   of   hyaluronic   acid   as   a potential alternative treatment of interstitial cystitis, recurrent  UTIs,  and  hemorrhagic  cystitis  remains unknown. Conflicts of interest There  are  no  financial  or  other  relationships  that might lead to a conflict of interest. Funding: None. References [1]  Available  at: http://wikipedia.org/wiki/Cochrane_Collab- oration . [2]  Miodosky M, Abdul-Hai A, Tsirigotis P, et al. Treatment of post-hematopoietic stem cell transplantation hemor- rhagic  cystitis  with  intravesicular  sodium  hyaluronate. Bone Marrow Transplant 2006;38:507–11. [3]  Morales A, Emerson L, Nickel JC. Intravesical hyaluronic acid  in  the  treatment  of  refractory  interstitial  cystitis. Urology 1997;49(5A suppl):111–3. [4]  Sato H, Takahashi T, Ide H. Antioxidant activity of syno- vial  fluid,  hyaluronic  acid  and  two  sub-components  of hyaluronic   acid.   Synovial   fluid   scavenging   effect   is enhanced in rheumatoid arthritis patients. Arch Rheum 1988;31:63–7. [5]  Goldberg RL, Toole BP. Hyaluronate inhibition of cell pro- liferation. Arth Rheum 1987;30:769–73. [6]  Abatangelo G, Martelli M, Vecchia P. Healing of hyaluronic acid-enriched  wounds:  histological  observations.  J  Surg Res 1983;35:410–4. [7]  Hadler  NM,  Napier  MA.  Structure  of  hyaluronic  acid  in synovial  fluid  and  its  influence  on  the  movement  of solutes. Sem Arth Rheum 1977;7:141–6. [8]  Hurst RE, Rhodes SW, Adamson PB, et al. Functional and structural  characteristics  of  the  glycosaminoglycans  of the bladder luminal surface. J Urol 1987;138:433–7. [9]  Parsons  CL.  The  therapeutic  role  of  sulphated  polysac- charides   in   urinary   bladder.   Urol   Clin   North   Am 1994;21:93–100. [10]  Goldberg RL, Tole BP. Hyaluronate inhibition of cell pro- liferation. Arthritis Rheum 1987;30:769–78. [11]  Morales A, Emerson L, Nickel JC, et al. Intravesical hya- luronic  acid  in  the  treatment  of  refractory  interstitial cystitis. J Urol 1996;156:45–8. [12]  Constantinides C, Manousakas T, Nikolopoulos P, et  al. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int 2004;93:1262–6. [13]  Gidwani   S,   Fairbank   A.   The   orthopaedic   approach to  managing  osteoarthritis  of  the  knee.  BMJ  2004;329: 1220–4. [14]  Kunz  LIZ,  Van  Rensen  ELJ,  Sterk  PJ.  Inhaled  hyaluronic acid   against   exercise-induced   bronchocostriction   in asthma. Pulm Pharmacol Ther 2006;19:286–91. [15]  Maltese A, Borzacchiello A, Mayol L, et al. Novel polysac- charides-based  viscoelastic  formulation  for  ophthalmic surgery:     rheological     characterization.     Biomaterials 2006;27:5134–42. [16]  Hertegard S, Hallen L, Laurent C, et al. Cross-linked hya- luronan used as augmentation substance for treatment of glottal insufficiency: safety aspects and vocal fold func- tion. Laryngoscope 2002;112:2211–9. [17]  Monheit GD, Coleman KM. Hyaluronic acid fillers. Derma- tol Ther 2006;19:141–50. [18]  Puri P, Pirker M, Mohanan N, et al. Subureteral dextrano- mer/hyaluronic acid injection as first line treatment in the management  of high grade vesicoureteral reflux. J Urol 2006;176:1856–9. [19]  Daha LK, Riedl CR, Lazar D, et al. Do cystometric findings predict   the   results   of   intravesical   hyaluronic   acid in   women   with   interstitial   cystitis?   Eur   Urol   2005; 47:393–7. [20]  Kallestrup EB, Jorgensen SS, Nordling J, et al. Treatment of interstitial cystitis with Cystistat: a hyaluronic acid prod- uct. Scand J Urol Nephrol 2005;39:143–7. [21]  Temml  C,  Wehrberger  C,  Riedl C,  et  al.  Prevalence  and correlates  for  interstitial  cystitis  symptoms  in  women participating  in  a  health  screening  project.  Eur  Urol 2007;51:803–9. european urology 51 (2007) 1534–1541 1539 </p>
                                        
                                            <p>2. 1.    Introduction Hyaluronic  acid  is  a  major  mucopolysaccharide found  widely  in  the  connective,  epithelial,  and neural  tissues.  It  is  one  of  the  main  components of the extracellular matrix that contributes signifi- cantly to cell proliferation and migration, and may also be involved in the progression and migration of some malignant tumors [1] . Hyaluronic acid in the urothelium constitutes a protective barrier [2,3] .It exhibits a variety of properties that may contribute to its prophylactic mechanism [4–10] . Among them are  (1)  inhibition  of  adherence  of  immune  com- plexes   to   polymorphonuclear   cells;   (2)   marked inhibition of leukocyte migration and aggregation, depending on viscosity; (3) regulation of fibroblast and endothelial cell proliferation; and (4) enhance- ment   of   connective   tissue   healing.   A   damaged glycosaminoglycan  layer  may  lead  to  direct  expo- sure of epithelial cells to components of urine; for this  reason  the  possibility  of  bacterial  adherence and   infection   increases [8–10] .   This   damage   is proposed to be a causative factor in the development of  interstitial  cystitis [11] ,  common  urinary  tract infections (UTIs) [12] , and hemorrhagic cystitis due to posthematopoietic stem cell transplantation [2] . Hyaluronic acid is used in clinical practice in the treatment of patients with osteoarthritis (by intra- articular  injections) [13] or  asthma [14] ;  in  certain ophthalmologic [15] and otologic [16] operations; in cosmetic  regeneration  and  reconstruction  tissue [17] ;  and  in  cystitis [2,3] and  vesicoureteral  reflux [18] . The aim of this article is to critically review the available evidence regarding the use of hyaluronic acid   as   an   alternative   treatment   of   interstitial cystitis,   recurrent   urinary   tract   infections,   and hemorrhagic cystitis. 2.    Interstitial cystitis Interstitial cystitis is a chronic disease characterized by  urinary  frequency,  bladder  pain,  nocturia,  and urgency.  It  usually  affects  women [19] .  The  pre- valence of interstitial cystitis ranges from 10 up to 510 cases per 100,000 population [20,21] . Interstitial cystitis is frequently a diagnosis of exclusion. Many etiologic factors [20,22–24] have been suggested for this  condition,  including  autoimmune  response, mast  cell  activation,  neuropathic  changes,  occult infection,  toxic  substances  in  the  urine,  and  a primary  defect  in  the  glycosaminoglycan  layer  of the  bladder  mucosa.  It  has  been  suggested  that  a defect in the glycosaminoglycan layer allows access of  different  components  of  urine,  such  as  ions, microorganisms, and toxic molecules, to the bladder urothelium [25,26] ,  and   urinary   hyaluronic   acid levels correlate with interstitial cystitis [27] . There  is  no  specific  treatment  for  interstitial cystitis  because  of  its  uncertain  cause  and  patho- genesis.  Tricyclic  antidepressants,  anti-inflamma- tory  drugs,  and  a  wide  range  of  epithelial-coating techniques  including  the  use  of  heparin,  sodium pentosan  polysulfate,  and  hyaluronic  acid  have been used [20,22,26,28–31] . Hyaluronic acid is con- sidered  a  good  candidate  for  glycosaminoglycan substitution.   In   addition,   heparin   and   dimethyl sulfoxide are often used in patients with interstitial cystitis. These agents’ actions are not quite clear, but they  supposedly  act  via  their  anti-inflammatory effects. Other agents for intravesical treatment are Bacillus  Calmette-Guerin  vaccine  and  botulinum toxin,  and  some  recent  studies  have  pointed  to resiniferatoxin and RDP58 [32] . 3.    Urinary tract infections UTI  is  a  very  common  type  of  bacterial  infection, especially in women. Not every patient with UTI has symptoms.  When  symptoms  are  present,  patients feel   urgency,   frequency,   nocturition   with   small voidal   volume,   bladder   or   utethra   pain   during urination,  suprapubic  discomfort,  and  sometimes fullness in the rectum. Presence of fever, pain in the back or side below the ribs, nausea, and vomiting indicates kidney infection [33] . Management of UTIs involves  administration  of  antibiotics,  but  a  high percentage  of  recurrent  infections  still  occur [12] . Contemporary   treatment   options   could   also   be estrogen replacement therapy [12] , use of cranberry juice [34] or  probiotics [35] ,  as  well  as  glycosami- noglycan  substitution  by  using  heparin,  sodium pentosan polysulfate, or hyaluronic acid [12] . 4.    Hemorrhagic cystitis Hemorrhagic cystitis is a  relatively  common (inci- dence: 7–68%) and potentially severe complication of high-dose chemoradiotherapy, especially in con- junction with hematopoietic stem cell transplanta- tion. There is no established effective treatment for this type of cystitis [2] . 5.    Literature search Using the online PubMed database, we searched for articles relevant to our study that were archived by european urology 51 (2007) 1534–1541 1535 </p>
                                        
                                            <p>5. September  2006.  The  key  words  we  used  in  our literature  searches  were  hyaluronic  acid,  hyaluro- nate, cystitis. 6.    Study selection and evaluation The focus of our study was in articles that described the  role  of  hyaluronic  acid  in  the  prevention  or treatment of different types of cystitis. Only English language studies were included in this review. We identified a total of 27 potentially relevant articles. From these, 15 were excluded because they did not focus on the topic of our study. In addition, 3 articles were excluded because they were animal studies. As a result 9 studies remained that met the inclusion criteria of our review. Relevant data were extracted from  each  study  and  tabulated.  The  information retrieved   included   the   number   of   patients,   the route of hyaluronic acid administration, the results (positive  or  negative),  and  the  follow-up  of  each study. 7.    Critical review of the available evidence From our literature search we found seven studies [19,20,22,26,36–39] that   investigated   the   role   of hyaluronic  acid  in  the  treatment  of  patients  with interstitial  cystitis  (total  number  of  patients:  172), one study [12] regarding the treatment of patients with recurrent UTIs (total number of patients: 40), and   one   study [2] regarding   the   treatment   of patients  with  hemorrhagic  cystitis  (total  number of  patients:  7).  In Table  1 we  present  the  data extracted from the relevant reviewed studies. Patients received four to six weekly intravesical installations of hyaluronic acid at a dose of 40 mg in a  volume  of  50 ml  of  phosphate-buffered  saline. Responders   then   received   monthly   doses.   The intravesical  installation  was  performed  with  the use  of  a  catheter,  under  sterile  conditions,  after removal of residual urine. The patients retained the intravesical hyaluronic acid for a minimum time of 30 min [2,12,19,20,22,26,36–39] . Kallestrup et al [20] found no correlation between the retention time in the  bladder  (range:  28–155 min)  and  the  effective- ness of hyaluronic acid. Gupta et al [21,37] and Daha et al [19] proposed the use of a positive potassium sensitivity test before the use of hyaluronic acid to identify patients  with predominant  epithelial dys- function, who are thought to be better responders to this treatment. The available data suggest that the total short- term response of patients with interstitial cystitis is from 30% [39] up to 73% [38] , and the long-term (3  yr)  response  of  such  patients  could  reach  55% [20] .Miodoskyetal [1] reported  that  the  total response to the treatment in patients with hemor- rhagic  cystitis  is  71%.  Constantinides  et  al [12] found that, in patients with recurrent UTIs, intra- vesical treatment with hyaluronic acid was asso- ciated  with  absence  of  recurrence  in  100%  and 70%  of  patients  during  5-mo  and  1-yr  follow-up, respectively. 8.    Adverse events The use of hyaluronic acid is usually well tolerated [2,12,19,20,22,26,36–39] ;  for  this  reason  high  com- pliance  with  the  treatment  was  achieved  in  the reviewed  studies  and  is  also  expected  in  clinical practice. No serious local or systemic adverse events were  mentioned  in  the  reviewed  studies,  except mild  bladder  irritation.  A  reported  adverse  event was bacterial cystitis that was most likely related to the repeated urinary catheterization rather than the therapeutic agent itself. 9.    Cost The  cost  of  each  intravesical  installation  of  hya- luronic acid is 120 UK pounds. This figure does not include the cost of the urinary catheterization, the cost of the services of the health care personnel, and the  loss  of  working  time  and  earnings  due  to  the need for intravesical administration of the drug [22] . For these reasons, we believe that cost-effectiveness analyses  regarding  the  use  of  hyaluronic  acid  in patients  with  the  examined  diseases  should  be performed. 10.    Limitations in the interpretation of the available evidence The   major   issue   in   interpreting   the   available evidence regarding the effectiveness and safety of hyaluronic  acid  for  the  examined  diseases  is  that there are only limited relevant published data. Thus, one   cannot   make   definitive   statements   on   the reviewed topics. In addition, an important limitation of the evaluated studies is the fact that only three of the  nine  reviewed  studies  were  randomized  con- trolled trials. It should be mentioned that, in two of these  three  trials,  hyaluronic  acid  was  compared with  placebo,  while  in  one  of  these  three  trials women   were   stratified   by   bladder   capacity   or european urology 51 (2007) 1534–1541 1538 </p>
                                        
                                            <p>1. Review – Female Urology – Incontinence Hyaluronic Acid: An Effective Alternative Treatment of Interstitial Cystitis, Recurrent Urinary Tract Infections, and Hemorrhagic Cystitis? Christos Iavazzo a , Stavros Athanasiou a , b , Eleni Pitsouni a , Matthew E. Falagas a , c , * a Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece b 1st Department of Obstetrics and Gynecology, Athens University School of Medicine, Athens, Greece c Department of Medicine, Tufts University School of Medicine, Boston, MA, USA european urology 51 (2007) 1534–1541 available at www.sciencedirect.com journal homepage: www.europeanurology.com Article info Article history: Accepted March 9, 2007 Published online ahead of print on March 20, 2007 Keywords: Hyaluronate Glycosaminoglycan replacement treatment Intravesical administration Cystitis Abstract Objectives: Hyaluronicacidisaprotectivebarrieroftheurothelium.A damaged  glycosaminoglycan  layer  may  increase  the  possibility  of  bacterial adherence and infection. This damage is proposed to be a causative factor in the development of interstitial cystitis, common urinary tract infections, and hemorrhagic cystitis due to posthematopoietic stem cell transplantation. The aim  of  this  article  was  to  review  the  available  data  regarding  the  use  of hyaluronic  acid  as  an  alternative  treatment  of  the  above-mentioned  condi- tions. Methods: Articles relevant to our review that were archived by September 2006 were retrieved from PubMed. Results: Nine relevant studies were identified and evaluated. Hyaluronic acid was administered intravesically at a dose of 40 mg every week for 4–6 wk; patients with  noted  improvement  received  two  additional  monthly  doses.  Short-term responses of patients with interstitial cystitis, hemorrhagic cystitis, and recur- rent urinary tract infections were 30–73% (7 studies), 71% (1 study), and 100% (1 study), respectively. The treatment was well tolerated except for occasional development  of  bacterial  cystitis.  The  cost  of  each  intravesical  installation  of hyaluronic acid is 120 UK pounds (excluding the cost of the urinary catheter- ization). Conclusions: The available clinical data regarding the effectiveness of hyaluronic acid  as  a  potential  treatment  of  patients  with  interstitial  cystitis,  recurrent urinary  tract  infections,  and  hemorrhagic  cystitis  are  limited.  There  is  need for  randomized  controlled  trials  for  further  investigation  of  this  important therapeutics question; these clinical trials should be disease-specific, blinded, and controlled,  and of a sufficient number  of patients. Until  such studies are available, intravesical instillation of hyaluronic acid cannot be unquestionably endorsed for use for the aforementioned diseases. # 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved. *  Corresponding author. Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Greece. Tel. +30 694 611 0000; Fax: +30 210 683 9605. E-mail address: <a href="../../cdn-cgi/l/email-protection.html" class="__cf_email__" data-cfemail="8de0a3ebece1eceaecfecdece4effea3eaff">[email&#160;protected]</a> (M.E. Falagas). 0302-2838/$ – see back matter # 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.    doi: 10.1016/j.eururo.2007.03.020 </p>
                                        
                                            <p></p>
                                        
                                    
                                </div>
                                <div role="tabpanel" class="tab-pane fade" id="statistic" slide-url="hyaluronic-acid-an-effective-alternative-treatment-of-interstitial-cystitis-recurrent-urinary-tract-infections-and-hemorrhagic-cystitis-50.html">
                                    <div class="row">
                                        <div class="col-lg-4">
                                            <h4 class="mt0 oe_slides_statistics_title">Nézetek</h4>
                                            <ul class="list-group">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">1249</span>
                                                    <i class="fa fa-play"></i> Total Views
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">952</span>
                                                    <i class="fa fa-circle-o"></i> Website Views
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">297</span>
                                                    <i class="fa fa-code"></i> Embedded Views
                                                </li>
                                            </ul>
                                        </div>

                                        <div class="col-lg-4">
                                            <h4 class="mt0 oe_slides_statistics_title">Műveletek</h4>
                                            <ul class="list-group">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="total-share">0</span>
                                                    <i class="fa fa-share-alt"></i> Social Shares
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">0</span>
                                                    <i class="fa fa-thumbs-up"></i> Likes
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">0</span>
                                                    <i class="fa fa-thumbs-down"></i> Nemkedvelések
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">0</span>
                                                    <i class="fa fa-comments-o"></i> Comments
                                                </li>
                                            </ul>
                                        </div>

                                        <div class="col-lg-4">
                                            <h4 class="mt0 oe_slides_statistics_title">Share count</h4>
                                            <ul class="list-group">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="facebook-badge">0</span>
                                                    <i class="fa fa-facebook-square"></i> Facebook
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="twitter-badge">0</span>
                                                    <i class="fa fa-twitter-square"></i> Twitter
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="linkedin-badge">0</span>
                                                    <i class="fa fa-linkedin-square"></i> LinkedIn
                                                </li>
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill" id="google-badge">0</span>
                                                    <i class="fa fa-google-plus-square"></i> Google+
                                                </li>
                                            </ul>
                                        </div>
                                    </div>
                                    <div class="row">
                                        <div class="col-lg-12">
                                            <h4 class="mt0"> Embeds
                                                <span class="badge badge-pill float-right">
                                                    3
                                                </span>
                                            </h4>
                                            <ul class="list-group" style="height: 150px;overflow: auto;">
                                                <li class="list-group-item">
                                                    <span class="badge badge-pill">30</span>
                                                    hbs.hu
                                                </li><li class="list-group-item">
                                                    <span class="badge badge-pill">1</span>
                                                    www.hbs.hu
                                                </li><li class="list-group-item">
                                                    <span class="badge badge-pill">2</span>
                                                    odoo.hbs.hu
                                                </li>
                                            </ul>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="col-xl-4 col-lg-4 col-md-12 col-12">
                    <ul class="nav nav-tabs" role="tablist">
                        <li class="nav-item"><a aria-controls="related" href="#related" class="nav-link active" data-toggle="tab">Kapcsolódó</a></li>
                        <li class="nav-item"><a aria-controls="most_viewed" href="#most_viewed" class="nav-link" data-toggle="tab">Most Viewed</a></li>
                    </ul>
                    <div class="tab-content">
                        <div role="tabpanel" id="related" class="tab-pane active mt4">
                            <div class="card">
                                <ul class="list-unstyled card-body">
                                    
                                    
                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="cuaj-5-6-e136-17.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/17/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="cuaj-5-6-e136-17.html"><h6 class="mb-1">cuaj-5-6-e136</h6></a>
            <small class="text-muted">
                1558 Views . <timeago class="timeago" datetime="2019-10-31 13:27:48.254982"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/18/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html"><h6 class="mb-1">Minimally invasive device for intravesical instillation-Lovasz-2019-International_Journal_of_Urology</h6></a>
            <small class="text-muted">
                1504 Views . <timeago class="timeago" datetime="2019-10-31 13:28:10.125299"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="cikk-a-neurourology-and-urodynamics-ban-2018-19.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/19/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="cikk-a-neurourology-and-urodynamics-ban-2018-19.html"><h6 class="mb-1">Cikk a Neurourology and Urodynamics-ban 2018.</h6></a>
            <small class="text-muted">
                1473 Views . <timeago class="timeago" datetime="2019-10-31 13:28:23.618732"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-treatment-checklist-20.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/20/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-treatment-checklist-20.html"><h6 class="mb-1">IC-BPS Treatment Checklist</h6></a>
            <small class="text-muted">
                1498 Views . <timeago class="timeago" datetime="2019-10-31 13:28:50.163748"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-diagnostic-algorhytm-21.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/21/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-diagnostic-algorhytm-21.html"><h6 class="mb-1">IC-BPS diagnostic algorhytm.</h6></a>
            <small class="text-muted">
                1488 Views . <timeago class="timeago" datetime="2019-10-31 13:29:57.450898"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="glycosaminoglycan-therapy-for-bladder-diseases-22.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/22/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="glycosaminoglycan-therapy-for-bladder-diseases-22.html"><h6 class="mb-1">Glycosaminoglycan Therapy for Bladder Diseases</h6></a>
            <small class="text-muted">
                1385 Views . <timeago class="timeago" datetime="2019-10-31 13:30:10.980936"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="essic-2017-budapest-abstracts-23.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/23/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="essic-2017-budapest-abstracts-23.html"><h6 class="mb-1">ESSIC 2017 Budapest abstracts</h6></a>
            <small class="text-muted">
                1464 Views . <timeago class="timeago" datetime="2019-10-31 13:30:38.129948"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="prevalence-of-symptoms-of-bladder-pain-syndrome-2011-24.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/24/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="prevalence-of-symptoms-of-bladder-pain-syndrome-2011-24.html"><h6 class="mb-1">Prevalence of Symptoms of Bladder Pain Syndrome 2011</h6></a>
            <small class="text-muted">
                1304 Views . <timeago class="timeago" datetime="2019-10-31 13:30:57.131521"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="the-urinary-microbiota-of-men-and-women-and-its-changes-in-women-during-bacterial-vaginosis-and-antibiotic-treatment-2017-25.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/25/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="the-urinary-microbiota-of-men-and-women-and-its-changes-in-women-during-bacterial-vaginosis-and-antibiotic-treatment-2017-25.html"><h6 class="mb-1">The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment. 2017</h6></a>
            <small class="text-muted">
                1362 Views . <timeago class="timeago" datetime="2019-10-31 13:35:55.689470"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="interstitial-cystitis-associated-urinary-metabolites-identified-by-mass-spectrometry-based-metabolomics-analysis-2016-26.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/26/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="interstitial-cystitis-associated-urinary-metabolites-identified-by-mass-spectrometry-based-metabolomics-analysis-2016-26.html"><h6 class="mb-1">Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis. 2016</h6></a>
            <small class="text-muted">
                1299 Views . <timeago class="timeago" datetime="2019-10-31 13:36:14.959707"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="pentosan-polysulfate-sodium-for-therapy-of-ic-urology-1990-27.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/27/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="pentosan-polysulfate-sodium-for-therapy-of-ic-urology-1990-27.html"><h6 class="mb-1">PENTOSAN POLYSULFATE SODIUM FOR THERAPY of IC Urology 1990</h6></a>
            <small class="text-muted">
                1414 Views . <timeago class="timeago" datetime="2019-10-31 13:37:27.415502"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="interstitial-cystitis-intravesical-therapy-tau-06-s2-s171-2017-28.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/28/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="interstitial-cystitis-intravesical-therapy-tau-06-s2-s171-2017-28.html"><h6 class="mb-1">Interstitial cystitis intravesical therapy tau-06-S2-S171 2017</h6></a>
            <small class="text-muted">
                1368 Views . <timeago class="timeago" datetime="2019-10-31 13:38:04.204366"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="novel-targeted-bladder-drug-delivery-systems-rru-7-169-2015-29.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/29/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="novel-targeted-bladder-drug-delivery-systems-rru-7-169-2015-29.html"><h6 class="mb-1">Novel targeted bladder drug-delivery systems rru-7-169 2015</h6></a>
            <small class="text-muted">
                1489 Views . <timeago class="timeago" datetime="2019-10-31 13:38:18.425299"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-administration-of-combined-hyaluronic-acid-ha-and-chondroitin-sulfate-cs-for-the-treatment-of-female-recurrent-urinary-tract-infections-2016-bmjopen-2015-009669-30.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/30/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-administration-of-combined-hyaluronic-acid-ha-and-chondroitin-sulfate-cs-for-the-treatment-of-female-recurrent-urinary-tract-infections-2016-bmjopen-2015-009669-30.html"><h6 class="mb-1">Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections 2016 bmjopen-2015-009669</h6></a>
            <small class="text-muted">
                1221 Views . <timeago class="timeago" datetime="2019-10-31 13:38:52.835202"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-treatment-with-highly-concentrated-hyaluronic-acid-and-chondroitin-sulphate-in-patients-with-recurrent-urinary-tract-infections-results-from-a-multicentre-survey-cuaj-9-10-e721-31.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/31/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-treatment-with-highly-concentrated-hyaluronic-acid-and-chondroitin-sulphate-in-patients-with-recurrent-urinary-tract-infections-results-from-a-multicentre-survey-cuaj-9-10-e721-31.html"><h6 class="mb-1">Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections- Results from a multicentre survey.cuaj-9-10-e721</h6></a>
            <small class="text-muted">
                1388 Views . <timeago class="timeago" datetime="2019-10-31 13:39:08.628954"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-and-glycosaminoglycans-replacement-therapy-2015-tau-04-06-638-32.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/32/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-and-glycosaminoglycans-replacement-therapy-2015-tau-04-06-638-32.html"><h6 class="mb-1">IC_BPS and glycosaminoglycans replacement therapy 2015 tau-04-06-638</h6></a>
            <small class="text-muted">
                1251 Views . <timeago class="timeago" datetime="2019-10-31 13:39:22.993300"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="managing-chronic-bladder-diseases-with-the-administration-of-exogenous-glycosaminoglycans-an-update-on-the-evidence-2016-urology-33.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/33/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="managing-chronic-bladder-diseases-with-the-administration-of-exogenous-glycosaminoglycans-an-update-on-the-evidence-2016-urology-33.html"><h6 class="mb-1">Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans- an update on the evidence 2016 Urology</h6></a>
            <small class="text-muted">
                1389 Views . <timeago class="timeago" datetime="2019-10-31 13:40:52.836690"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/34/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="hyaluronic-acid-and-its-composites-as-a-local-antimicrobial-antiadhesive-barrier-2017-jbjiv02p0063-34.html"><h6 class="mb-1">Hyaluronic Acid and Its Composites as a Local Antimicrobial-Antiadhesive Barrier 2017.jbjiv02p0063</h6></a>
            <small class="text-muted">
                1311 Views . <timeago class="timeago" datetime="2019-10-31 13:45:41.648470"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="evidence-based-criteria-for-the-pain-of-ic-bps-in-women-2008-nihms43157-35.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/35/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="evidence-based-criteria-for-the-pain-of-ic-bps-in-women-2008-nihms43157-35.html"><h6 class="mb-1">Evidence-based criteria for the pain of IC_BPS in women 2008 nihms43157</h6></a>
            <small class="text-muted">
                1301 Views . <timeago class="timeago" datetime="2019-10-31 13:45:59.326213"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="intravesical-glycosaminoglycan-replacement-with-chondroitin-2015-article-306-36.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/36/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="intravesical-glycosaminoglycan-replacement-with-chondroitin-2015-article-306-36.html"><h6 class="mb-1">Intravesical Glycosaminoglycan Replacement with Chondroitin_2015_Article_306</h6></a>
            <small class="text-muted">
                1359 Views . <timeago class="timeago" datetime="2019-10-31 13:46:19.773972"></timeago>
            </small>
        </div>
    </li>

                                    
                                </ul>
                            </div>
                        </div>
                        <div role="tabpanel" id="most_viewed" class="tab-pane  mt4">
                            <div class="card">
                                <ul class="list-unstyled card-body">
                                    
                                    
                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="sugarvedo-ruhazat-ismerteto-3.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/3/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="sugarvedo-ruhazat-ismerteto-3.html"><h6 class="mb-1">Sugárvédő ruházat ismertető</h6></a>
            <small class="text-muted">
                3284 Views . <timeago class="timeago" datetime="2018-10-20 14:31:25.547995"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="op-set-system-5.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/5/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="op-set-system-5.html"><h6 class="mb-1">OP Set System</h6></a>
            <small class="text-muted">
                3044 Views . <timeago class="timeago" datetime="2018-11-16 13:38:03.543744"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="kompresszios-polya-felhelyezese-8.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/8/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="kompresszios-polya-felhelyezese-8.html"><h6 class="mb-1">Kompressziós pólya felhelyezése</h6></a>
            <small class="text-muted">
                2846 Views . <timeago class="timeago" datetime="2018-11-16 13:39:25.884480"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="kotszer-polya-l-r-6.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/6/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="kotszer-polya-l-r-6.html"><h6 class="mb-1">Kötszer Pólya L&amp;R</h6></a>
            <small class="text-muted">
                2643 Views . <timeago class="timeago" datetime="2018-11-16 13:38:35.611223"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="nedves-sebkezeles-flyer-l-r-7.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/7/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="nedves-sebkezeles-flyer-l-r-7.html"><h6 class="mb-1">Nedves sebkezelés flyer L&amp;R</h6></a>
            <small class="text-muted">
                2438 Views . <timeago class="timeago" datetime="2018-11-16 13:38:59.835920"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="pdb-actico-ulcersys-liner-10.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/10/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="pdb-actico-ulcersys-liner-10.html"><h6 class="mb-1">PDB_Actico UlcerSys Liner</h6></a>
            <small class="text-muted">
                2324 Views . <timeago class="timeago" datetime="2018-11-16 13:39:54.728282"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="scican-statim-g4-2.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/2/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="scican-statim-g4-2.html"><h6 class="mb-1">SciCan STATIM G4</h6></a>
            <small class="text-muted">
                2321 Views . <timeago class="timeago" datetime="2018-10-20 14:10:02.671163"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="pdb-actico-ulcersys-9.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/9/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="pdb-actico-ulcersys-9.html"><h6 class="mb-1">PDB_Actico UlcerSys</h6></a>
            <small class="text-muted">
                2209 Views . <timeago class="timeago" datetime="2018-11-16 13:39:42.488113"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="urostill-hasznalati-utmutato-v1-1-12.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/12/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="urostill-hasznalati-utmutato-v1-1-12.html"><h6 class="mb-1">UroStill_hasznalati_utmutato_v1.1</h6></a>
            <small class="text-muted">
                2038 Views . <timeago class="timeago" datetime="2019-10-31 13:22:24.531510"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="koronavirus-jarvany-61.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/61/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="koronavirus-jarvany-61.html"><h6 class="mb-1">KORONAVIRUS JARVANY</h6></a>
            <small class="text-muted">
                1774 Views . <timeago class="timeago" datetime="2020-04-09 15:16:22.317496"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="scican-statim-g4-1.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/1/image_thumb.jpg"/>
        </a>
        <div class="media-body">
            <a href="scican-statim-g4-1.html"><h6 class="mb-1">SciCan Statim G4</h6></a>
            <small class="text-muted">
                1709 Views . <timeago class="timeago" datetime="2018-10-20 14:09:31.661802"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="new-aiding-device-for-self-instillation-v2-16.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/16/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="new-aiding-device-for-self-instillation-v2-16.html"><h6 class="mb-1">New_aiding_device_for_self-instillation_v2</h6></a>
            <small class="text-muted">
                1690 Views . <timeago class="timeago" datetime="2019-10-31 13:23:48.863175"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="kitpack-11.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/11/image_thumb.jpg"/>
        </a>
        <div class="media-body">
            <a href="kitpack-11.html"><h6 class="mb-1">Kitpack</h6></a>
            <small class="text-muted">
                1684 Views . <timeago class="timeago" datetime="2018-11-16 14:52:39.736537"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="icbps-szoszedet-14.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/14/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="icbps-szoszedet-14.html"><h6 class="mb-1">ICBPS_SZÓSZEDET</h6></a>
            <small class="text-muted">
                1620 Views . <timeago class="timeago" datetime="2019-10-31 13:23:06.826135"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-faq-s-and-appropriate-answers-mumbai-2019-15.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/15/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-faq-s-and-appropriate-answers-mumbai-2019-15.html"><h6 class="mb-1">IC - FAQ-s and appropriate answers Mumbai 2019</h6></a>
            <small class="text-muted">
                1612 Views . <timeago class="timeago" datetime="2019-10-31 13:23:19.219912"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="urostill-users-manual-v1-1-13.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/13/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="urostill-users-manual-v1-1-13.html"><h6 class="mb-1">UroStill_Users_Manual_v1.1</h6></a>
            <small class="text-muted">
                1605 Views . <timeago class="timeago" datetime="2019-10-31 13:22:47.677753"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="l-r-corporate-film-4.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/4/image_thumb.jpg"/>
        </a>
        <div class="media-body">
            <a href="l-r-corporate-film-4.html"><h6 class="mb-1">L&amp;R Corporate Film</h6></a>
            <small class="text-muted">
                1601 Views . <timeago class="timeago" datetime="2018-11-14 15:53:51.760680"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="cuaj-5-6-e136-17.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/17/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="cuaj-5-6-e136-17.html"><h6 class="mb-1">cuaj-5-6-e136</h6></a>
            <small class="text-muted">
                1558 Views . <timeago class="timeago" datetime="2019-10-31 13:27:48.254982"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/18/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="minimally-invasive-device-for-intravesical-instillation-lovasz-2019-international-journal-of-urology-18.html"><h6 class="mb-1">Minimally invasive device for intravesical instillation-Lovasz-2019-International_Journal_of_Urology</h6></a>
            <small class="text-muted">
                1504 Views . <timeago class="timeago" datetime="2019-10-31 13:28:10.125299"></timeago>
            </small>
        </div>
    </li>

                                    
                                        
    <li class="media mt-3">
        <a class="mr-3" href="ic-bps-treatment-checklist-20.html">
            <img class="oe_slides_apart_small" alt="slide.name" src="../../web/image/slide.slide/20/image_thumb.png"/>
        </a>
        <div class="media-body">
            <a href="ic-bps-treatment-checklist-20.html"><h6 class="mb-1">IC-BPS Treatment Checklist</h6></a>
            <small class="text-muted">
                1498 Views . <timeago class="timeago" datetime="2019-10-31 13:28:50.163748"></timeago>
            </small>
        </div>
    </li>

                                    
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    
                </main>
                <footer class="bg-light o_footer">
                    <div id="footer" class="oe_structure oe_structure_solo">
      <section class="s_text_block pb8 pt40">
        <div class="container">
          <div class="row" style="border-top: solid 1px #ddd; padding-top: 30px;">
            <div class="col-lg-4">
              <h5>További tartalmak</h5>
              <ul class="list-unstyled">
                <li>
                  <a href="../../blog/hirek-esemenyek-1.html" data-original-title="" title="" aria-describedby="tooltip310735">Blog</a>
                  <br/>
                  <a href="../../adatkezelesi-tajekoztato.html">Adatkezelési tájékoztató</a>
                </li>
                <li>
                  <br/>
                </li>
              </ul>
            </div>
            <div class="col-lg-4" id="connect">
              <h5>Elérhetőségek</h5>
              <ul class="list-unstyled">
                <li>
                  <i class="fa fa-phone"></i>
                  <span data-note-id="2">+36 1 452 1700</span>
                </li>
                <li>
                  <i class="fa fa-envelope"></i>
                  <span><a href="../../cdn-cgi/l/email-protection.html" class="__cf_email__" data-cfemail="5f363139301f373d2c71372a">[email&#160;protected]</a></span>
                </li>
              </ul>
              <p> </p>
            </div>
            <div class="col-lg-4">
              <h5>
                <span>HBS Medical</span>
                <small> – <a href="../../aboutus.html" data-original-title="" title="" aria-describedby="tooltip425138">Kapcsolat</a></small>
              </h5>
              <p>&nbsp;<br/></p>
            </div>
          </div>
        </div>
      </section>
    </div>
  <div class="o_footer_copyright">
            <div class="container">
                <div class="row">
                    <div class="col-lg-6 text-muted text-center text-md-left">
                        <span>Copyright &copy;</span> <span itemprop="name">HBS Medical</span>
                        
    

                    </div>
                    <div class="col-lg-6 text-right o_not_editable">
                        
    <div class="o_brand_promotion text-muted">
        Az oldalt készítette:
        <a href="https://eyssen.hu/" target="_blank"><img src="../../web/image/606/eyssen_logo_blue.png" width="120"/></a>
    </div>

                    </div>
                </div>
            </div>
        </div>
    </footer>
            </div>
        <script data-cfasync="false" src="../../cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script id="tracking_code">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

            ga('create', _.str.trim('UA-52898474-1'), 'auto');
            ga('send','pageview');
        </script>
    
        
            </body>
        
<!-- Mirrored from hbs.hu/slides/slide/hyaluronic-acid-an-effective-alternative-treatment-of-interstitial-cystitis-recurrent-urinary-tract-infections-and-hemorrhagic-cystitis-50 by HTTrack Website Copier/3.x [XR&CO'2014], Mon, 31 May 2021 16:22:26 GMT -->
</html>
    
    
